← Back to ANRO

Alto Neuroscience, Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Sep 2025Filed 12/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Sep 2024Filed 12/11/2025Jun 2024Filed 12/11/2025Mar 2024Filed 12/11/2025
−$28−$26−$14−$18−$15−$17−$16−$13
−$0.65−$0.80−$0.52−$0.65−$0.56−$0.62−$0.60−$0.76
4333272727272718

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.